Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Clear cell renal cell carcinoma (CCRCC) is linked to adipogenic differentiation.
• Histone modification, particularly by histone demethylase plant homeodomain finger 2 (PHF2), plays a role in adipogenesis.
• PHF2 may function as a tumor suppressor through epigenetic regulation of p53 and its reduced expression is observed in other cancers.

Purpose of the Study:

• To investigate the expression of PHF2 in CCRCC specimens.
• To determine the correlation between PHF2 expression and clinicopathological features and prognosis of CCRCC.

Main Methods:

• Immunohistochemistry was used to examine PHF2 expression.
• The study included 254 CCRCC tissues and 56 non-neoplastic renal tissues.
• Tissue microarray blocks were prepared for analysis.

Main Results:

• High PHF2 expression was observed in 59.1% of CCRCC cases, while 40.1% showed low expression.
• High PHF2 expression was significantly associated with lower Fuhrman nuclear grade, smaller tumor size, and lower overall stage.
• High PHF2 expression correlated with longer cancer-specific survival and progression-free survival.

Conclusions:

• Low PHF2 expression is associated with increased aggressiveness and poorer prognosis in CCRCC.
• PHF2 expression levels may serve as a potential prognostic biomarker for CCRCC.